The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension

Ir J Med Sci. 2004 Oct-Dec;173(4):200-3. doi: 10.1007/BF02914551.

Abstract

Background: Recent data suggest that inflammatory reactions are involved in the pathogenesis of cerebral ischaemia.

Aim: To investigate whether certain inflammatory genetic polymorphisms are associated with the occurrence of ischaemic stroke.

Methods: We investigated the prevalence of six polymorphisms in cytokine genes (IL-6, TNF-alpha, TNF-beta, IL-1beta, IL-10, and IL-1Ralpha) in a group of ischaemic stroke patients (n = 105) and in a control population (n = 389). We analysed the prevalence of these polymorphisms in different stroke subtypes and in relation to outcome six months post-stroke.

Results: There was no significant variation in cytokine gene polymorphism frequencies between control and stroke populations or for different stroke subtypes. Subgroup analysis demonstrated that the prevalence of the IL-6 -174 CC genotype was significantly lower in stroke patients without a history of hypertension compared to controls.

Conclusion: The IL6 -174 CC genotype may be protective against stroke in those patients who have no history of hypertension. Further studies are required to verify these findings.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Brain Ischemia / genetics*
  • Chi-Square Distribution
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Hypertension
  • Interleukin-1 / genetics
  • Interleukin-10 / genetics
  • Interleukin-6 / genetics*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Interleukin-1
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10